Related Experiment Videos
Outpatient cervical ripening using a sustained-release prostaglandin E2 vaginal insert.
S A Tassone1, C R Pearman, W F Rayburn
1Department of Obstetrics and Gynecology, University of Oklahoma, Health Sciences Center, Oklahoma City.
The Journal of Reproductive Medicine
|July 10, 2001
Summary
A sustained-release prostaglandin E2 vaginal insert for outpatient cervical ripening showed high rates of contractions and early removal. These findings suggest the insert is not suitable for use outside a hospital setting.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Cervical ripening is crucial for labor induction.
- Outpatient management aims to improve patient comfort and reduce healthcare costs.
Purpose of the Study:
- To evaluate the efficacy and safety of a sustained-release prostaglandin E2 vaginal insert for outpatient cervical ripening.
- To assess the feasibility of using this method in a simulated outpatient setting.
Main Methods:
- A clinical trial involving 111 patients was conducted.
- Patients received a sustained-release prostaglandin E2 vaginal insert.
- The setting simulated outpatient care for cervical ripening.
Main Results:
- 23.4% of patients experienced regular contractions.
- 27.9% of patients had the insert removed before 12 hours.
- High rates of contractions and early removal indicate potential challenges for outpatient use.
Conclusions:
- The sustained-release prostaglandin E2 vaginal insert demonstrated significant contractile activity and early removal rates.
- These outcomes suggest that the insert's use is not ideal for outpatient cervical ripening.
- Further research may be needed to optimize delivery or patient selection for outpatient settings.